Video

ADHD Coaching an Emerging Tool for Patients

Author(s):

An ADHD coach can work on more goal-based plans for individuals with ADHD.

Coaching for attention deficit/hyperactivity disorder (ADHD) could be a game changer in supplementing the existing strategies of therapy and medication to further help this patient population.

In a poster presented during the American Professional Society of ADHD and Related Disorders (APSARD) 2021 Annual Conference, a team of researchers presented data from a focus group looking at ADHD coaching as an emerging tool for both pediatric and adult patients with the disorder.

In an interview with HCPLive®, Elizabeth Ahmann, Research Director of the Springer Institute and Micah Saviet, Director of the Springer Institute, explained how the results of the focus group show what the role of ADHD might be moving forward.

The researchers believe the role of ADHD coaching ultimately is to work on personalized goal oriented plans with the individual and craft a way to achieve those goals. It ideally will be used in conjunction and coordination with the clinician and psychiatrists.

One of the aims of the focus group is to come up with guidelines for how ADHD coaches can best communicate with clients and better understand how to network with other professionals involved in the process.

However, the research team believes further research is needed to better explore interprofessional communication among other professionals.

Related Videos
Marcelo Kugelmas, MD | Credit: South Denver Gastroenterology
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
Eric Lawitz, MD | Credit: UT Health San Antonio
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
© 2024 MJH Life Sciences

All rights reserved.